dc.contributor | Departament de Salut |
dc.contributor.author | Programa d’Harmonització Farmacoterapèutica |
dc.date.accessioned | 2023-06-14T12:16:13Z |
dc.date.available | 2023-06-14T11:49:22Z |
dc.date.available | 2023-06-14T11:59:48Z |
dc.date.available | 2023-06-14T12:16:13Z |
dc.date.issued | 2020-05-06 |
dc.identifier.citation | Programa d’Harmonització Farmacoterapèutica. Coronavirus SARS-CoV-2: ús extrahospitalari de la hidroxicloroquina [fullet]. Barcelona: Servei Català de la Salut; 2020. |
dc.identifier.uri | https://hdl.handle.net/11351/9753.3 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Pneumonia; Prescription; Hydroxychloroquine; Individualized evaluation |
dc.description.abstract | Recommendations for the initiation and follow-up of hydroxychloroquine treatment in the SARS-CoV-2 pneumonia in the outpatient setting. |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Coronavirus |
dc.subject | Infeccions per coronavirus |
dc.subject | Pneumònia - Tractament |
dc.subject | Medicaments - Administració |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Hydroxychloroquine |
dc.subject.mesh | Pneumonia |
dc.subject.mesh | /drug therapy |
dc.title | Coronavirus SARS-CoV-2: ús extrahospitalari de la hidroxicloroquina [fullet] |
dc.type | info:eu-repo/semantics/other |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | Hidroxicloroquina |
dc.subject.decs | neumonía |
dc.subject.decs | /tratamiento farmacológico |
dc.type.subtype | Fullet |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |